Dr Reddy’s sells 14-drug portfolio to Senores Pharma for US market expansion

Share it

On Tuesday, Dr Reddy’s shares closed nearly flat at ₹11,120.15 on the National Stock Exchange (NSE), while Senores Pharmaceuticals surged 6.03% to ₹562.50 following the announcement.

Leave a Comment

Your email address will not be published. Required fields are marked *